KRAS and familial pancreatic carcinoma: Although RNA interference (RNAi) provides an alternative therapeutic approach for inhibiting KRAS gene function, the efficientdelivery of siRNAs remains a problem and early attempts to develop small molecules targeting KRAS as a direct pancreatic cancer therapy were not successful.